# Sonosa Medical, Inc. — Form D

Sonosa Medical, Inc. of BALTIMORE, MD, a company, filed a Form D exempt-offering notice with the SEC on 2022-03-15. The offering totals $2.5M, of which $240K was reported sold. Industry: Biotechnology.

## Offering

- Filed: 2022-03-15
- Form: D
- Accession: 0001014100-22-000014
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $2.5M
- Amount sold: $240K
- Remaining: $2.3M
- Investors: 2
- Date of first sale: 2021-11-23
- Revenue range: Decline to Disclose
- SEC file number: 021-437249

## Issuer

- Name: Sonosa Medical, Inc.
- CIK: 0001913459
- Entity type: Corporation
- Jurisdiction: MARYLAND
- Incorporated: 2019
- Address: 300 WEST PRATT STREET, BALTIMORE, MD, 21201
- Phone: 443-410-4337

## Officers, directors & promoters (5)

| Name | Role | Location |
| --- | --- | --- |
| Gilmer Blankenship | Director | Baltimore, MD |
| Amy Hizoune | Director | Baltimore, MD |
| Stephen Restaino | Director | Baltimore, MD |
| Stephen Restaino | Executive Officer | Baltimore, MD |
| Stephen Restaino | Promoter | Baltimore, MD |

## More

- [CIK 1913459 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1913459&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001014100-22-000014.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.